Wearable Atrial Fibrillation Detection Devices Market Analysis And Forecast To 2031: By Component (Hardware, Software), By Application (Smart Watches, Patches, Holter Monitors, Others), By End-user (Hospitals & Clinics, Ambulatory Facilities, Others), And

Wearable Atrial Fibrillation Detection Devices Market Analysis And Forecast To 2031: By Component (Hardware, Software), By Application (Smart Watches, Patches, Holter Monitors, Others), By End-user (Hospitals & Clinics, Ambulatory Facilities, Others), And Region

The global wearable atrial fibrillation detection devices market was valued at USD 2.3 billion in 2021 and it is anticipated to grow up to USD 7.0 billion by 2031, at a CAGR of 11.8% during the forecast period.

A wearable atrial fibrillation detection device is a wearable device that is used to detect atrial fibrillation, a type of heart arrhythmia. Atrial fibrillation is a condition in which the hearts electrical impulses are out of sync, causing the heart to beat irregularly. This can lead to a number of complications, including stroke. Wearable atrial fibrillation detection devices use sensors to detect the hearts electrical activity and can alert the user if atrial fibrillation is detected. These devices are often worn on the chest, and some models can also be worn on the wrist.
Global Wearable Atrial Fibrillation Detection Devices Market Scope and Report Structure

Market Trends and Drivers
There are several key drivers of the wearable atrial fibrillation detection devices market. One of the most important drivers is the increasing prevalence of atrial fibrillation. Atrial fibrillation is a type of arrhythmia, or irregular heartbeat, that affects millions of people around the world. The condition can lead to serious health complications, including stroke, so early detection is critical. Another key driver of the wearable atrial fibrillation detection devices market is the aging population. As people age, they are more likely to develop atrial fibrillation. This is due to a variety of factors, including increased risk of cardiovascular disease and changes in the structure and function of the heart. Advances in technology are also driving the market for wearable atrial fibrillation detection devices. These devices are becoming more sophisticated and are able to provide more accurate and detailed information about a person’s heart health. This is important for both diagnosis and treatment of atrial fibrillation.
Market Restraints and Challenges
One of the key restraints in the wearable atrial fibrillation detection devices market is the lack of awareness about the condition and the available treatments. In addition, the high cost of these devices is another challenge that limits their adoption.
Global Wearable Atrial Fibrillation Detection Devices Market Segmental Overview
The report analyses the global wearable atrial fibrillation detection devices market based on component, application, end-user, and region.

Global Wearable Atrial Fibrillation Detection Devices Market by Component

Based on component, it is segmented into hardware, and software. Among these, the hardware segment is estimated to account for a substantial share in the wearable atrial fibrillation detection devices market through 2031. This rise can be attributed to the availability of a range of wearable devices in healthcare. Some of these devices include smart patches, rings, watches and others. Of these, ring-type wearables, equipped with deep learning analysis of PPG signals could help in the accurate diagnosis of AF without depending on electrocardiography. Similar devices enable the continuous monitoring of AF in high-risk populations.

Global Wearable Atrial Fibrillation Detection Devices Market by Application

Based on the application, the wearable atrial fibrillation detection devices market is segmented into Smart Watches, Patches, Holter Monitors, and Others. The smart watches segment is projected to register appreciable growth by 2028 owing to the extensive adoption of these devices and their demonstrated accuracy in screening individuals for AF. Furthermore, the use of PPG in smartwatches helps patients in taking an ECG with the tap of a button. The devices can be considered as screening tools for people at high risk of the condition because of increased age or factors pertaining to cardiovascular risk.

Global Wearable Atrial Fibrillation Detection Devices Market by End-user

With regards to end-user, the wearable atrial fibrillation detection devices market is divided into hospitals & clinics, ambulatory facilities, and others. In 2021, the hospitals and clinics segment accounted for the highest market share and is anticipated to maintain its dominance during the forecast period. This can be attributed to well-equipped infrastructure, availability of advanced devices, a rise in the number of practitioners & patients, and an increase in collaborations to help reduce the burden of diagnosis & treatment. Technological advancements, shifting interest toward ambulatory centers for treatment, and availability of advanced devices like ECG patches & portable Holter for ambulatory ECG monitoring have led to an increase in the number of patients opting for diagnosis in the ambulatory facilities, driving the market growth. As these devices facilitate immediate transfer of data pertaining to outpatient procedures, demand for ambulatory centers is expected to increase for accurate assessment of cardiac arrhythmias.

Geographical Analysis of Global Wearable Atrial Fibrillation Detection Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America wearable atrial fibrillation detection devices market revenue is poised to grow significant CAGR during the forthcoming years. This upsurge is due to an increase in clearances by regulators in the region. For instance, in October 2021, Withings secured the approval of the FDA for its ScanWatch. The device is capable of measuring blood oxygen levels from the wrist and can help in the detection of AF via a medical-grade ECG. Moreover, rising incidence of AFib in the region, aging population, technological advancements, shifting patient preference toward ambulatory ECG monitoring, the launch of next-generation wireless ECG monitoring devices, and technological collaborations between manufacturers will fuel the regional growth.
Major Players in the Global Wearable Atrial Fibrillation Detection Devices Market
The key players in the wearable atrial fibrillation detection devices market Apple, Inc., AliveCor, Cardiac Insight, Applied Cardiac Systems, LifeWatch, Garmin, CardioNet, Dr Trust, Phablecare, and Omron. among others.
COVID-19 Impact
The SARS-CoV-2 pandemic led to the prevention of a number of patients from availing in-person services. This advocated the requirement for remote patient monitoring solutions and wearable devices for minimizing interruptions in healthcare. While the number of people themselves deploying these devices was far low before the coronavirus crisis, the pandemic led to a dramatic rise in these figures. This has created the need for the development and rollout of technologically advanced wearable cardiac monitoring devices and solutions on the market.
Recent Developments

In July 2022, Xplore Lifestyle collaborates with an Israeli company to launch CardiacSense, world's first medical grade and wearable continuous monitoring device.
In November 2021, Philips signed agreement to acquire Cardiologs, a medical technology company focused on transforming cardiac diagnostics using cloud technology and artificial intelligence (AI). This acquisition complements the company’s product portfolio of cardiac monitoring and diagnostics devices, thereby offering revenue growth opportunities in the market.
In October 2021, Withings has received FDA clearance for a watch it is capable of detecting atrial fibrillation through a medical-grade ECG and measuring blood oxygen levels from the wrist.
In March 2021, AliveCor entered into a partnership with AstraZeneca for the development of new disease management solutions in CVRM (cardiovascular, renal, and metabolism) therapeutic areas.
In December 2020, Apple received FDA clearance for an updated version of the tech giant’s ECG feature, which enabled the addition of a category dubbed A-Fib with high heart rate. The product came more than two years after the company secured a De Novo clearance for its first version of ECG reading.
In February 2020, AliveCor received approval from the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) to launch KardiaMobile in Mexico. The company has partnered with Inpharamo to implement the medical-grade ECG across the country. This has enabled company to expand its global footprint as well as customer base in the market.

Frequently Asked Questions
Q1. How big is the wearable atrial fibrillation detection devices market?

Ans. The global wearable atrial fibrillation detection devices market was valued at USD 2.3 billion in 2021 and it is anticipated to grow up to USD 7.0 billion by 2031, at a CAGR of 11.8% during the forecast period.

Q2. What is the wearable atrial fibrillation detection devices market growth rate?

Ans. The growth rate of the wearable atrial fibrillation detection devices market is 11.8%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the wearable atrial fibrillation detection devices market in 2021.

Q4. Which segment accounted for the largest wearable atrial fibrillation detection devices market share?

Ans. By end user, the hospitals segment accounted for the largest wearable atrial fibrillation detection devices market share.

Q5. Who are the key players in the flexible endoscopes market?

Ans. The global wearable atrial fibrillation detection devices market report includes players such as  Apple, Inc., AliveCor, Cardiac Insight, Applied Cardiac Systems, LifeWatch, Garmin, CardioNet, Dr Trust, Phablecare, and Omron, among others.

Q6. What are the factors driving the wearable atrial fibrillation detection devices market growth?

Ans. The major factors driving the growth of the market are growing prevalence of cardiovascular diseases and expenditure on cardiac health globally

Q7. What are the key growth strategies of wearable atrial fibrillation detection devices market players?

Ans. The key growth strategies of wearable atrial fibrillation detection devices market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the wearable atrial fibrillation detection devices market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the wearable atrial fibrillation detection devices market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.